Tetrahydrocurcumin(Renibus Therapeutics)

N/A

Report date: 2024/11/07 16:30:23

Base Information

Drug NameTetrahydrocurcumin(Renibus Therapeutics)
Drug Alias NameRBT-2
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAdropin stimulants
TargetsAdropin
Therapy Area/IndicationsRenal Insufficiency
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesRenibus Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesRenibus Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsRenal Insufficiency
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A